GILT: Shaping the MHC Class II-Restricted Peptidome and CD4(+) T Cell-Mediated Immunity
- PMID: 24409178
- PMCID: PMC3885806
- DOI: 10.3389/fimmu.2013.00429
GILT: Shaping the MHC Class II-Restricted Peptidome and CD4(+) T Cell-Mediated Immunity
Abstract
The MHC class II-restricted antigen processing pathway generates peptide:MHC complexes in the endocytic pathway for the activation of CD4(+) T cells. Gamma-interferon-inducible lysosomal thiol reductase (GILT) reduces protein disulfide bonds in the endocytic compartment, thereby exposing buried epitopes for MHC class II binding and presentation. T cell hybridoma responses and elution of MHC class II bound peptides have identified GILT-dependent epitopes, GILT-independent epitopes, and epitopes that are more efficiently presented in the absence of GILT termed GILT-prevented epitopes. GILT-mediated alteration in the MHC class II-restricted peptidome modulates T cell development in the thymus and peripheral tolerance and influences the pathogenesis of autoimmunity. Recent studies suggest an emerging role for GILT in the response to pathogens and cancer survival.
Keywords: GILT; MHC class II; antigen processing and presentation; autoimmunity; tumor immunity.
Figures

Similar articles
-
Low GILT Expression is Associated with Poor Patient Survival in Diffuse Large B-Cell Lymphoma.Front Immunol. 2013 Dec 4;4:425. doi: 10.3389/fimmu.2013.00425. eCollection 2013. Front Immunol. 2013. PMID: 24409177 Free PMC article.
-
Functional requirements for the lysosomal thiol reductase GILT in MHC class II-restricted antigen processing.J Immunol. 2006 Dec 15;177(12):8569-77. doi: 10.4049/jimmunol.177.12.8569. J Immunol. 2006. PMID: 17142755
-
GILT in Thymic Epithelial Cells Facilitates Central CD4 T Cell Tolerance to a Tissue-Restricted, Melanoma-Associated Self-Antigen.J Immunol. 2020 Jun 1;204(11):2877-2886. doi: 10.4049/jimmunol.1900523. Epub 2020 Apr 8. J Immunol. 2020. PMID: 32269095 Free PMC article.
-
Diverse cellular and organismal functions of the lysosomal thiol reductase GILT.Mol Immunol. 2015 Dec;68(2 Pt A):124-8. doi: 10.1016/j.molimm.2015.06.008. Epub 2015 Jun 23. Mol Immunol. 2015. PMID: 26116226 Free PMC article. Review.
-
Disulfide reduction in the endocytic pathway: immunological functions of gamma-interferon-inducible lysosomal thiol reductase.Antioxid Redox Signal. 2011 Aug 1;15(3):657-68. doi: 10.1089/ars.2010.3684. Epub 2011 Apr 20. Antioxid Redox Signal. 2011. PMID: 21506690 Free PMC article. Review.
Cited by
-
B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential Triggers.Front Immunol. 2020 May 8;11:760. doi: 10.3389/fimmu.2020.00760. eCollection 2020. Front Immunol. 2020. PMID: 32457742 Free PMC article. Review.
-
High GILT Expression Is Associated with Improved Survival in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibition.Cancers (Basel). 2022 Apr 28;14(9):2200. doi: 10.3390/cancers14092200. Cancers (Basel). 2022. PMID: 35565329 Free PMC article.
-
IFI30 Is a Novel Immune-Related Target with Predicting Value of Prognosis and Treatment Response in Glioblastoma.Onco Targets Ther. 2020 Feb 5;13:1129-1143. doi: 10.2147/OTT.S237162. eCollection 2020. Onco Targets Ther. 2020. PMID: 32103982 Free PMC article.
-
Assessing the immunogenicity risk of salmon calcitonin peptide impurities using in silico and in vitro methods.Front Pharmacol. 2024 Aug 9;15:1363139. doi: 10.3389/fphar.2024.1363139. eCollection 2024. Front Pharmacol. 2024. PMID: 39185315 Free PMC article.
-
Microglia express gamma-interferon-inducible lysosomal thiol reductase in the brains of Alzheimer's disease and Nasu-Hakola disease.Intractable Rare Dis Res. 2018 Nov;7(4):251-257. doi: 10.5582/irdr.2018.01119. Intractable Rare Dis Res. 2018. PMID: 30560017 Free PMC article.
References
-
- Jensen PE. Acidification and disulfide reduction can be sufficient to allow intact proteins to bind class II MHC. J Immunol (1993) 150(8 Pt 1):3347–56 - PubMed
-
- Collins DS, Unanue ER, Harding CV. Reduction of disulfide bonds within lysosomes is a key step in antigen processing. J Immunol (1991) 147(12):4054–9 - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials